NCT04793152View on ClinicalTrials.gov

Vancomycin Dosing for Serious MRSA Infections: A Non-inferiority Randomized Trial of Trough Level Versus AUC/MIC

NARecruitingINTERVENTIONAL
Enrollment

700

Participants

Timeline

Start Date

March 20, 2023

Primary Completion Date

July 31, 2029

Study Completion Date

October 31, 2029

Conditions
MRSA
Interventions
DRUG

Vancomycin

Administration as outlined

Trial Locations (4)

L8L 2X2

RECRUITING

Hamilton Health Sciences, Hamilton

L8N 4A6

RECRUITING

St. Joseph's Healthcare Hamilton, Hamilton

K7L 2V7

RECRUITING

Kingston Health Sciences Centre, Kingston

H3H 2R9

RECRUITING

McGill University Health Centre, Montreal

Sponsors
All Listed Sponsors
collaborator

Physician Services Incorporated

UNKNOWN

collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

lead

Anthony Bai

OTHER